Loading
Codexis
Codexis, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes enzymes and other classes of proteins through its platform to drive improvements in manufacturing complex therapeutics. Codexis serves customers in the United States.
Funding
Every round, secondary, debt facility or acquisition involving Codexis that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—